Clinical Trials on Growth

Total 1120 results

University Hospital of Split

Completed

Indicators of Growth, Nutritional Status and Comorbide Disorders of Newborns With Down Syndrome (DownSy)

Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction

Croatia
Tel-Aviv Sourasky Medical Center

Unknown

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity

Pregnancy Complications | Preeclampsia | Placental Abruption | Intrauterine Fetal Death | Intrauterine Fetal Growth Restriction

Israel
Abbott Nutrition

Not yet recruiting

Preterm Infants Fed a Human Milk Fortifier

Growth
Rabin Medical Center

Recruiting

Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls

Low Weight | Growth Problem

Israel
Merck KGaA, Darmstadt, Germany
Merck S.A. Columbia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia (ECOS COL)

Growth Disorders

Colombia
Merck KGaA, Darmstadt, Germany
Merck A.B., Sweden

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden (ECOS SWE)

Growth Disorders

Sweden
Merck KGaA, Darmstadt, Germany
Merck spol.s.r.o., Czech Republic

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic (ECOS CZ)

Growth Disorders

Czechia
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia (ECOS AUS)

Growth Disorders

Australia
Merck KGaA, Darmstadt, Germany
Merck Gesellschaft mbH, Austria

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria (ECOS AUT)

Growth Disorders

Austria
Merck KGaA, Darmstadt, Germany
EMD Serono, a division of EMD Inc., Canada

Completed

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment (ECOS CAN)

Growth Disorders

Canada
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ LLC

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East (ECOS UAE)

Growth Disorders

Germany
Genentech, Inc.

Completed

National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

Growth Disorders
University of Alabama at Birmingham
Genentech, Inc.

Completed

Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

Growth Disorders
Maastricht University Medical Center

Unknown

Women Specific Cardiac Recovery After Preeclampsia (WeCare)

Pregnancy | Pre-Eclampsia | Intrauterine Growth Restriction | HELLP Syndrome

Netherlands
Assiut University

Not yet recruiting

Growth Pattern and Characteristics of Cardiac Pediatric Patients

Growth Disorders
Second Affiliated Hospital, School of Medicine,...
Nantong University; Taizhou Hospital; The Second Affiliated Hospital of Kunming... and other collaborators

Recruiting

Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site

Wound Healing | Fibroblast Growth Factors

China
Children's National Research Institute

Active, not recruiting

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Growth Disorders

United States
University of Karachi
Advanced Education & Research Center

Completed

To Observe the Psychophysiological Alterations in Traumatic Stress Subjects

Traumatic Stress, Post-Traumatic Growth

Pakistan
Merck KGaA, Darmstadt, Germany
Merck Ltd., Taiwan; Merck Pte. Ltd., Singapore; PT Merck Tbk., Indonesia, an...

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore) (ECOS TW ID SG)

Growth Disorders

Singapore, Taiwan, Indonesia
Merck KGaA, Darmstadt, Germany
Merck Kft., Hungary

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary (ECOS HUN)

Growth Disorders

Hungary
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy (ECOS ITA)

Growth Disorders

Italy
Merck KGaA, Darmstadt, Germany
Merck spol. s r.o., Slovakia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia (ECOS SVK)

Growth Disorders

Slovakia
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France (ECOS FRA)

Growth Disorders

France
Merck KGaA, Darmstadt, Germany
Merck Quimica Argentina S.A.I.C

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina (ECOS ARG)

Growth Disorders

Argentina
Merck KGaA, Darmstadt, Germany
Merck S.A. de C.V., Mexico

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico (ECOS MEX)

Growth Disorders

Mexico
Merck KGaA, Darmstadt, Germany
Merck A.E., Greece

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece (ECOS GRE)

Growth Disorders

Greece
Central Hospital, Nancy, France

Unknown

Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies (EVUPA)

Preeclampsia | Intra-uterine Growth Restriction

France
Skane University Hospital
University of California, Davis; Umeå University; Arla Foods

Active, not recruiting

Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula

Sleep | Growth | Infection

Sweden
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK (ECOS UK)

Growth Disorders

United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

Saizen® E-Device User Trial

Growth Disorders
Merck KGaA, Darmstadt, Germany
Merck Ltd.

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea (ECOS KOR)

Growth Disorders

Korea, Republic of
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain (ECOS ESP)

Growth Disorders

Spain
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment (ECOS CHN)

Growth Disorders

China
University of Palermo

Completed

Adrenal Function in GHD Children

Growth Hormone Treatment | Adrenal; Functional Disturbance

Italy
International Centre for Diarrhoeal Disease Research...

Completed

Promotion of Complimentary Feeding Practices in Bangladesh

Growth Disorders

Bangladesh
University of Florence

Terminated

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Preeclampsia
University College Dublin
Royal College of Surgeons, Ireland; National Maternity Hospital, Ireland; Perinatal...

Completed

Trial of Early Screening Test for Pre-eclampsia and Growth Restriction (TEST)

Placenta Diseases | Pre-Eclampsia | Fetal Growth Retardation | Eclampsia Preeclampsia | Foetal Growth Restriction

Ireland
Hospital Universitario 12 de Octubre
Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReN

Recruiting

Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction (COLIGROW)

Fetal Growth Retardation

Spain
University of Wisconsin, Madison
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Placental Lesions in Fetal Growth Restrictions

Fetal Growth Retardation

United States
University of Aarhus
Aarhus University Hospital; Snedkermester Sophus Jacobsen and hustru Astrid... and other collaborators

Completed

Day to Day Variation in Fetal Heart Rate Variability ((FHRV))

Fetal Growth Retardation

Denmark
University of Aarhus
Aarhus University Hospital; Snedkermester Sophus Jacobsen and hustru Astrid... and other collaborators

Unknown

Fetal Heart Rate Variability and Fetal Growth Restriction ((FGR))

Fetal Growth Retardation

Denmark
National Human Genome Research Institute (NHGRI)

Completed

Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation

Genetics | Growth Disorder | PIK3CA-Related Overgrowth Spectrum (PROS)

United States
Tehran University of Medical Sciences

Unknown

Sildenafil and Uteroplacental Perfusion

Fetal Growth Retardation

Iran, Islamic Republic of
UMC Utrecht
Stichting Achmea Gezondheidszor

Recruiting

OPtimal TIming of COrticosteroids in Early-onset Fetal Growth REstriction: the OPTICORE Study (OPTICORE)

Fetal Growth Retardation

Netherlands
Central Hospital, Nancy, France

Completed

Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction

Fetal Growth Retardation

France
Istanbul Bakirkoy Maternity and Children Diseases...

Completed

Doppler and AFV for Outcome Prediction ın FGR

Fetal Growth Retardation

Turkey
Centre Hospitalier Universitaire de Saint Etienne

Completed

Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction (GROWTH)

Fetal Growth Retardation

France
National University Hospital, Singapore

Completed

Epigenetic Markers in Growth Restricted Human Pregnancies: a Case-controlled Study

Fetal Growth Retardation

Singapore
UMC Utrecht

Unknown

Antenatal Allopurinol in Intrauterine Growth Restriction

Fetal Growth Retardation

Netherlands
University of Aarhus

Not yet recruiting

Next-generation Effects of Vitamin D Supplementation in Pregnancy

Immune System Diseases | Growth | Child Development | Vitamin D Supplementation

Clinical Trials on Growth

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations